Filing Details
- Accession Number:
- 0001179110-19-005257
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-29 17:35:19
- Reporting Period:
- 2019-04-25
- Accepted Time:
- 2019-04-29 17:35:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1587070 | Jaime Contreras | 100 Abbott Park Road Abbott Park IL 60064 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares Without Par Value | Acquisiton | 2019-04-25 | 46,016 | $44.40 | 80,722 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Acquisiton | 2019-04-25 | 36,716 | $59.94 | 117,438 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Disposition | 2019-04-25 | 70,400 | $70.00 | 47,038 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2019-04-25 | 12,332 | $70.02 | 34,706 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Acquisiton | 2019-04-26 | 80,860 | $38.40 | 115,566 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Disposition | 2019-04-26 | 57,962 | $78.11 | 57,604 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Option (right to buy) | Disposition | 2019-04-25 | 46,016 | $0.00 | 46,016 | $44.40 |
| Common Shares | Option (right to buy) | Disposition | 2019-04-25 | 36,716 | $0.00 | 36,716 | $59.94 |
| Common Shares | Option (right to buy) | Disposition | 2019-04-26 | 80,860 | $0.00 | 80,860 | $38.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 46,016 | 2019-02-17 | 2027-02-16 | No | 4 | M | Direct |
| 73,430 | 2019-02-16 | 2028-02-15 | No | 4 | M | Direct |
| 0 | 2019-02-19 | 2026-02-18 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares Without Par Value | 22 | Indirect | Profit Sharing Trust |
| Common Shares Without Par Value | 153,319 | Indirect | Jaime Contreras Marvan 2006 Living Trust |
| Common Shares Without Par Value | 2,227 | Indirect | By Spouse |
| Common Shares Without Par Value | 12,081 | Indirect | Living Trust (by spouse) |
Footnotes
- Balance in the Abbott Laboratories Stock Retirement Trust as of April 25, 2019.
- Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
- The reporting person disclaims beneficial ownership of all securities held by his spouse.
- Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
- Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Billionaire Hedge Funds
